KeyBank National Association
VRNA

KeyBank National Association’s Verona Pharma VRNA Stock Holding History

KeyBank National Association’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,460
Closed -$611K – 1225
2025
Q2 		$611K Hold
6,460
– – ﹤0.01% 703
2025
Q1 		$410K Hold
6,460
– – ﹤0.01% 843
2024
Q4 		$300K Buy
+6,460
New +$243K ﹤0.01% 997

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

KeyBank National Association's VRNA Position: Q3 2025 in Review

KeyBank National Association sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 6,460 shares — an estimated $611K sold.

KeyBank National Association first reported a position in VRNA in Q4 2024 and held it in 3 quarters. The position peaked at $611K in Q2 2025. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

  • KeyBank National Association reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
  • KeyBank National Association sold 6,460 Verona Pharma shares in Q3 2025, an estimated $611K.
  • KeyBank National Association first reported a position in Verona Pharma in Q4 2024 and held it in 3 quarters.
  • KeyBank National Association's Verona Pharma position peaked at $611K in Q2 2025.
  • 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on KeyBank National Association's 13F filing for Q3 2025, filed 4 Nov 2025.